Clinical review 79: Angiotensin II: an insulin-sensitizing vasoactive hormone?
Morris
A D
AD
Department of Pharmacology, Ninewells Hospital and Medical School, Dundee, Scotland.
Donnely
R
R
D000804:Angiotensin II / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006439:Hemodynamics; D006801:Humans; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance; D007668:Kidney / Q000187:drug effects / Q000502:physiology; D012039:Regional Blood Flow; D012084:Renin-Angiotensin System / Q000502:physiology*; D014662:Vasoconstrictor Agents
D007328:Insulin; D014662:Vasoconstrictor Agents; D000804:Angiotensin II